2019 annual financial data

China SXT Pharmaceuticals, Inc. - Class A Ordinary Shares 2019 Operating margin

China SXT Pharmaceuticals, Inc. - Class A Ordinary Shares 2019 operating margin…

Direct answer

Operating margin was 25.24%.

Operating income was 1,769,492 USD and net income was 1,539,227 USD.
Operating cash flow was 239,192 USD.
Alpha Vantage

Get free China SXT Pharmaceuticals, Inc. - Class A Ordinary Shares email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
7,012,026 USD
Operating income
1,769,492 USD
Net income
1,539,227 USD
Operating cash flow
239,192 USD

Explore related company data

View all 2019 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Net marginView Operating cash flow marginView all China SXT Pharmaceuticals, Inc. - Class A Ordinary Shares financial years